Hilde Bigler

Safety, tolerability, and pharmacokinetics of ICL670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia.

Renzo Galanello, Antonio Piga, Daniele Alberti et al. · PubMed · 2003 · 171 citations

Pharmacotherapy, Iron Deficiency, Transfusion-dependent Iron Overload +16

Safety, Tolerability, and Pharmacokinetics of ICL670, a New Orally Active Iron‐Chelating Agent in Patients with Transfusion‐Dependent Iron Overload Due to β‐Thalassemia

Renzo Galanello, Antonio Piga, Daniele Alberti et al. · The Journal of Clinical Pharmacology · 2003 · 131 citations

Therapeutic Drug Monitoring, Iron Complex, Pharmacokinetic Modeling +14

Pharmacokinetics of the Oral Direct??Renin Inhibitor Aliskiren Alone and??in Combination with Irbesartan in??Renal Impairment

Sujata Vaidyanathan, Hilde Bigler, C M Yeh et al. · Clinical Pharmacokinetics · 2007 · 67 citations

Medicinal Chemistry, Urology, Oral Direct +11

Evaluation of the pharmacokinetic interaction between fluvastatin XL and cyclosporine in renal transplant recipients

Hallvard Holdaas, Edward H. Hagen, Anders Åsberg et al. · International Journal of Clinical Pharmacology and Therapeutics · 2006 · 27 citations

Bioequivalence study of a valsartan tablet and a capsule formulation after single dosing in healthy volunteers using a replicated crossover design

Romain Séchaud, Philipp Graf, Hilde Bigler et al. · International Journal of Clinical Pharmacology and Therapeutics · 2002 · 21 citations